Saham Gland Pharma sentuh rekor tertinggi 52 pekan usai rilis laporan keuangan

Rabu, 20 Mei 2026

Dilaporkan oleh AI

Saham Gland Pharma mencapai rekor tertinggi baru dalam 52 pekan setelah perusahaan melaporkan kinerja yang kuat untuk kuartal Maret dan setahun penuh. Unit Eropa, Cenexi, menunjukkan tanda-tanda pemulihan, sementara peluncuran produk baru dan penambahan kapasitas turut mendukung prospek perusahaan.

Saham Gland Pharma naik ke level tertingginya dalam setahun menyusul rilis angka kuartalan dan tahunan yang solid. Perusahaan menyoroti peningkatan profitabilitas di anak usahanya di Eropa, Cenexi, sebagai faktor positif utama.

Artikel Terkait

ARS Pharmaceuticals reports strong start to 2026 in earnings call

ARS Pharmaceuticals held its first quarter 2026 earnings conference call on May 15, highlighting early momentum in the new year. Company executives emphasized growth drivers including expanded access for its neffy product. The call featured forward-looking statements about the firm's commercial progress.

Mutual funds boost pharma and nbfc holdings in april

Rabu, 13 Mei 2026 Dilaporkan oleh AI

Indian fund managers directed fresh investments into pharmaceutical and non-banking financial companies during April. The moves targeted defensive stocks amid concerns over oil prices and tensions in West Asia.

Eropa

European equities suffer steep weekly losses amid Middle East tensions

Teknologi

LG Electronics India shares rise with strong analyst outlook

Bisnis

Nine BSE smallcap stocks surged up to 170% with strong Q4 profits

DAX reaches six-week high

Germany's DAX index hit 24,260 points intraday on Thursday, its highest level in six weeks, closing at 24,154 points up 0.4 percent. Investors are optimistic amid hopes for an end to Middle East hostilities between Iran and the US. The S&P 500, Nikkei, and MSCI World also reached records.

Mcx reports 291 percent surge in q4 net profit

Jumat, 08 Mei 2026 Dilaporkan oleh AI

Multi Commodity Exchange of India posted a sharp rise in earnings for the quarter ended March. Consolidated net profit reached 530 crore rupees, up 291 percent from the prior year. The exchange also announced a dividend of 8 rupees per share.

Bisnis